SEC Form D private-offering filing

Edesa Biotech, Inc.

Name: Edesa Biotech, Inc. - new SEC Form D private-offering filing, Markham, ON, Canada
Published: 2026-06-26

A new SEC Form D private-offering notice from Markham, ON, Canada, a $3,500,000 filer-stated offering target in Biotech. The source filing is one click away.

Edesa Biotech, Inc. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing treatments for inflammatory and immune-related diseases, including respiratory and dermatological conditions.

Filed 2026-06-26Filed to raise $3,500,000First money in 2026-06-16Raised so far $3,499,986HQ (as filed) Markham, ON, CanadaSector Biotech ✓Stage (inferred) SeedCall status Non-US principal office

Source linked the Form D on EDGAR↗Website verified edesabiotech.com↗Named in the filing 9 executives & directors

Open this row on the live feed →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.